Merck, the FDA, and the Vioxx Recall
페이지 정보
작성일 22-12-30 01:21
본문
Download : Merck, the FDA, and the Vioxx Recall.pptx
Merck, the FDA, and the Vioxx Recall
_SLIDE_1_
Merck, the FDA, and the Vioxx Recall
_SLIDE_2_
Introduction of Merck
In 2005 the company ranked fourth in sales, after Pfizer, Johnson & Johnson, and GlaxoSmithKline.
In assets and market value, it ranked fifth. However, Merck ranked first in profits, earning $7.33 billion on $30.78 billion in sales.
Company
Sales ($bil)
Profits ($bil)
Assets ($bil)
Market value($bil)
Pfizer
40.36
6.20
120.06
285.27
Johnson & Johnson
40.01
6.74
46.66
160.96
GlaxosmithKline
34.16
6.34
29.19
124.79
Merck
30.78
7.33
42.59
108.76
_SLIDE_3_
1851
Dr. Ernst Christian Friedrich Schering begins developing and selling pharmaceutical products in Berlin. Three years later, the company opened its first production facility.
1891
Merck&Co. opens its doors in United States. The U.S. subsidiary’s patent company, E. Merck, was originally founded in Darmstadt, Germany, in 1668
1933
Merck dedicates its first research labotories in Rahway, NJ.
1944
A collaborat…(To be continued )
Download : Merck, the FDA, and the Vioxx Recall.pptx( 67 )
순서
레포트/기타
설명
Merck, the FDA, and the Vioxx Recall , Merck, the FDA, and the Vioxx Recall기타레포트 , Merck the FDA and the Vioxx Recall
Merck, the FDA, and the Vioxx Recall
Merck,the,FDA,and,the,Vioxx,Recall,기타,레포트
다.
